Skip main navigation (Press Enter).
Log in
Toggle navigation
Search Options
Log in
Home
About
Purpose, Mission, Vision, and Values
Leadership
Mac Baldrige Society
Directory
History of Baldrige
Donor Privacy
Charitable Disclosure Statement
Contact Us
FAQs
Resources
Learn
Education
General Courses
Lean Six Sigma Courses
Strategic Planning & Management Training
Degree Programs
Support Education
Knowledge Center
Glossary
Leader Dialogue
Research
Insights
White Papers
Chronicle of Leadership and Management
Events
Baldrige Resource Center
×
Back to Library
Operational Excellence in Process Development in Drug Substance Production
0
Recommend
Title:
Operational Excellence in Process Development in Drug Substance Production
Presenter(s):
Ken Green, Ph.D.
,
Klaus Mauch
Length:
120 minutes
Added:
Thursday, January 21, 2021
Description:
About this webinar
This presentation will highlight Samsung Biologics (SBL) approach to align process development activities with technology transfer and cGMP manufacturing. This alignment allows for rapid technology transfer with robust and compliant manufacturing. In addition, the alignment of process development with regulatory requirements allows SBL to provide a comprehensive regulatory CMC data package including process controls, validation, product comparability and stability.
Process development at SBL is embedded within the manufacturing organization and as such colleagues have extensive understanding of at-scale equipment and manufacturing operations across all SBL facilities ranging from 1,000L to 15,000L scale. With 62 licensed products manufactured at SBL, process development colleagues have amassed a broad range of experience and best practice across diverse cell culture and purification processes.
The application of standardized process operating procedures enables process development to streamline laboratory scale models and testing to accurately predict at-scale process performance. Technology transfer accelerants include the application of standardized process platforms, manufacturing best practice and small scale laboratory/virtual models. Finally, the development of robust transactional processes for process characterization, technology transfer and process validation enables their efficient application across SBL to fully support cGMP manufacturing corresponding to the product lifecycle phase.
#Webinar
#Excellence
#Process
#Green
#BriteTALK
#Mauch
Statistics
0 Favorited
0 Comments
2 Views
Related Entries and Links
No Related Resource entered.
The Foundation for the Malcolm Baldrige National Quality Award, Inc. is a 501(c)(3) nonprofit organization
| EIN 59-2891462 | NAICS 813211 (Grantmaking) 611430 (Professional and Management Development Training) | DUNS 004808751 |
1717 Pennsylvania Ave NW Suite 1025, Washington, DC 20006 | Phone (202) 559-9195
Copyright 2024. All rights reserved.
Powered by Higher Logic